CSL Behring Revenue and Competitors
Estimated Revenue & Valuation
- CSL Behring's estimated annual revenue is currently $1.4B per year.
- CSL Behring's estimated revenue per employee is $155,000
Employee Data
- CSL Behring has 9234 Employees.
- CSL Behring grew their employee count by 5% last year.
CSL Behring Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 8 | 0% | N/A | N/A |
#2 | $3.3M | 21 | 11% | N/A | N/A |
#3 | $1.4M | 5 | -17% | N/A | N/A |
#4 | $2.3M | 6 | 0% | N/A | N/A |
#5 | $10.5M | 57 | 2% | N/A | N/A |
#6 | $0.7M | 7 | 17% | N/A | N/A |
#7 | $4.8M | 21 | -16% | N/A | N/A |
#8 | $1.6M | 9 | 29% | N/A | N/A |
#9 | $7.4M | 40 | 3% | N/A | N/A |
#10 | $1.9M | 8 | 0% | N/A | N/A |
What Is CSL Behring?
ZLB develops, produces and markets high-quality biological drugs made from human plasma and operates plasma collection centres and a laboratory in the United States of America.ZLB is one of the world’s leading manufacturers of intravenously administered polyvalent immunoglobulins. Immunoglobulin preparations and albumin solutions are manufactured in accordance with international safety and quality standards at the production plants of ZLB Bioplasma AG in Bern (Switzerland) which have been licensed by the Swiss health authorities and the US FDA.
keywords:N/A
N/A
Total Funding
9234
Number of Employees
$1.4B
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CSL Behring's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Assoc. Director Marketing - Pulmonary & Transplant Medicine | Reveal Email/Phone |
2 | Clinical Safety Therapeutic Area Head - Immunology | Reveal Email/Phone |
3 | VP Researh and Development and Therapeutic Area | Reveal Email/Phone |
4 | Senior Director, Global Risk and Insurance Management | Reveal Email/Phone |
5 | Global Head Regions | Reveal Email/Phone |
6 | Sr. Director, Global Healthcare Policy & External Affairs | Reveal Email/Phone |
7 | Senior Manager Method Development | Reveal Email/Phone |
8 | Coagulation Manager | Reveal Email/Phone |
9 | Global Head Logistics | Reveal Email/Phone |
10 | Senior Director, Global Clinical Programs, Hematology Clinical Research and Development | Reveal Email/Phone |
CSL Behring News
At CSL Plasma, however, there is no exchange of money due to the fact that the plasma collected is then used by CSL Behring for their litany of...
... by CSL Behring to approve the potential gene therapy EtranaDez ... CSL Behring's head of global regulatory affairs, said in a press...
"As the first gene therapy candidate for hemophilia B, this pivotal regulatory milestone brings CSL Behring one step closer to delivering on the...
Just days after Thermo Fisher Scientific prepped to expand a St. Louis plant, the company announced it’s taking over a new, 1.5 million-square-foot site in Switzerland with plans to add 200 new employees. The move is a part of a May 2020 partnership with CSL and the site, slat ...
Uplifting Athletes Young Investigator Draft Presented by CSL Behring PHILADELPHIA (PRWEB) March 31, 2021 Uplifting Athletes, a nonprofit organization serving the Rare Disease Community, awarded $140,000 in medical research grants last night at its Young Investigator Draft Presented by CSL Behr ...
Other Companies in King of Prussia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12450M | 9957 | 4% | $25M |